Sumitomo Pharma Co.ltd. (4506) Press Release
Additional Explanation Regarding the Report “Sumitomo Chemical and Sumitomo Pharmaceutical: The 116 billion yen Swiss Shuffle”
Earlier from Sumitomo Pharma Co.ltd
- Regarding a Report Concerning Sumitomo Pharma
- Presentation Material (Conference on Q1 FY2026 Financial Results)
- Matters Concerning Controlling Shareholders, Etc.
- Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026